Cargando…

Ribitol restores functionally glycosylated α-dystroglycan and improves muscle function in dystrophic FKRP-mutant mice

O-mannosylated α-dystroglycan (α-DG) serves as receptors for cell–cell and cell–extracellular matrix adhesion and signaling. Hypoglycosylation of α-DG is involved in cancer progression and underlies dystroglycanopathy with aberrant neuronal development. Here we report that ribitol, a pentose alcohol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cataldi, Marcela P., Lu, Peijuan, Blaeser, Anthony, Lu, Qi Long
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6110760/ https://www.ncbi.nlm.nih.gov/pubmed/30150693 http://dx.doi.org/10.1038/s41467-018-05990-z

Ejemplares similares

ISPD Overexpression Enhances Ribitol-Induced Glycosylation of α-Dystroglycan in Dystrophic FKRP Mutant Mice
por: Cataldi, Marcela P., et al.
Publicado: (2019)

NAD+ enhances ribitol and ribose rescue of α-dystroglycan functional glycosylation in human FKRP-mutant myotubes
por: Ortiz-Cordero, Carolina, et al.
Publicado: (2021)

Distinct expression of functionally glycosylated alpha-dystroglycan in muscle and non-muscle tissues of FKRP mutant mice
por: Blaeser, Anthony, et al.
Publicado: (2018)

Overexpression of Mutant FKRP Restores Functional Glycosylation and Improves Dystrophic Phenotype in FKRP Mutant Mice
por: Tucker, Jason D., et al.
Publicado: (2018)

ISPD produces CDP-ribitol used by FKTN and FKRP to transfer ribitol phosphate onto α-dystroglycan
por: Gerin, Isabelle, et al.
Publicado: (2016)

Progressive Dystrophic Pathology in Diaphragm and Impairment of Cardiac Function in FKRP P448L Mutant Mice
por: Blaeser, Anthony, et al.
Publicado: (2016)

Ribitol enhances matriglycan of α-dystroglycan in breast cancer cells without affecting cell growth
por: Lu, Pei J., et al.
Publicado: (2020)

Efficacy of Gene Therapy Is Dependent on Disease Progression in Dystrophic Mice with Mutations in the FKRP Gene
por: Vannoy, Charles Harvey, et al.
Publicado: (2017)

The functional O-mannose glycan on α-dystroglycan contains a phospho-ribitol primed for matriglycan addition
por: Praissman, Jeremy L, et al.
Publicado: (2016)

Crystal structures of fukutin-related protein (FKRP), a ribitol-phosphate transferase related to muscular dystrophy
por: Kuwabara, Naoyuki, et al.
Publicado: (2020)

Dose-Dependent Effects of FKRP Gene-Replacement Therapy on Functional Rescue and Longevity in Dystrophic Mice
por: Vannoy, Charles Harvey, et al.
Publicado: (2018)

FKRP-dependent glycosylation of fibronectin regulates muscle pathology in muscular dystrophy
por: Wood, A. J., et al.
Publicado: (2021)

The Small Leucine-Rich Repeat Proteoglycan Biglycan Binds to α-Dystroglycan and Is Upregulated in Dystrophic Muscle
por: Bowe, Mark A., et al.
Publicado: (2000)

Skeletal, cardiac, and respiratory muscle function and histopathology in the P448Lneo− mouse model of FKRP-deficient muscular dystrophy
por: Yu, Qing, et al.
Publicado: (2018)

Functional Glycosylation of Dystroglycan Is Crucial for Thymocyte Development in the Mouse
por: Liou, Li-Ying, et al.
Publicado: (2010)

Ribitol dose-dependently enhances matriglycan expression and improves muscle function with prolonged life span in limb girdle muscular dystrophy 2I mouse model
por: Wu, Bo, et al.
Publicado: (2022)

B4GAT1 is the priming enzyme for the LARGE-dependent functional glycosylation of α-dystroglycan
por: Praissman, Jeremy L, et al.
Publicado: (2014)

Fukuyama-type congenital muscular dystrophy and defective glycosylation of α-dystroglycan
por: Saito, Fumiaki, et al.
Publicado: (2011)

Fer kinase regulates cell migration through α-dystroglycan glycosylation
por: Yoneyama, Tohru, et al.
Publicado: (2012)

The glucuronyltransferase B4GAT1 is required for initiation of LARGE-mediated α-dystroglycan functional glycosylation
por: Willer, Tobias, et al.
Publicado: (2014)

Mutations in ISPD cause Walker-Warburg syndrome and defective glycosylation of α-dystroglycan
por: Roscioli, Tony, et al.
Publicado: (2012)

Flow Cytometry for the Analysis of α-Dystroglycan Glycosylation in Fibroblasts from Patients with Dystroglycanopathies
por: Stevens, Elizabeth, et al.
Publicado: (2013)

Development of Rabbit Monoclonal Antibodies for Detection of Alpha-Dystroglycan in Normal and Dystrophic Tissue
por: Fortunato, Marisa J., et al.
Publicado: (2014)

Plectin 1f scaffolding at the sarcolemma of dystrophic (mdx) muscle fibers through multiple interactions with β-dystroglycan
por: Rezniczek, Günther A., et al.
Publicado: (2007)

LARGE Expression Augments the Glycosylation of Glycoproteins in Addition to α-Dystroglycan Conferring Laminin Binding
por: Zhang, Zhen, et al.
Publicado: (2011)

Ribitol in Solution Is an Equilibrium of Asymmetric Conformations
por: Ohno, Shiho, et al.
Publicado: (2021)

Senolytic elimination of senescent macrophages restores muscle stem cell function in severely dystrophic muscle
por: Liu, Lei, et al.
Publicado: (2022)

Identification and Modeling of a GT-A Fold in the α-Dystroglycan Glycosylating Enzyme LARGE1
por: Righino, Benedetta, et al.
Publicado: (2020)

β-Dystroglycan Restoration and Pathology Progression in the Dystrophic mdx Mouse: Outcome and Implication of a Clinically Oriented Study with a Novel Oral Dasatinib Formulation
por: Mantuano, Paola, et al.
Publicado: (2021)

Defects in Glycosylation Impair Satellite Stem Cell Function and Niche Composition in the Muscles of the Dystrophic Large(myd) Mouse
por: Ross, Jacob, et al.
Publicado: (2012)

Longitudinal functional and imaging outcome measures in FKRP limb-girdle muscular dystrophy
por: Leung, Doris G., et al.
Publicado: (2020)

Structural flexibility of human α‐dystroglycan
por: Covaceuszach, Sonia, et al.
Publicado: (2017)

An Immunological Analysis of Dystroglycan Subunits: Lessons Learned from a Small Cohort of Non-Congenital Dystrophic Patients
por: Pavoni, Ernesto, et al.
Publicado: (2011)

Xylosyl- and glucuronyltransferase functions of LARGE in α-dystroglycan modification are conserved in LARGE2
por: Inamori, Kei-ichiro, et al.
Publicado: (2013)

Exogenous expression of the glycosyltransferase LARGE1 restores α-dystroglycan matriglycan and laminin binding in rhabdomyosarcoma
por: Beltrán, Daniel, et al.
Publicado: (2019)

Zebrafish models for human FKRP muscular dystrophies
por: Kawahara, Genri, et al.
Publicado: (2010)

Transgenic Overexpression of LARGE Induces α-Dystroglycan Hyperglycosylation in Skeletal and Cardiac Muscle
por: Brockington, Martin, et al.
Publicado: (2010)

Metabolomics Analysis of Skeletal Muscles from FKRP-Deficient Mice Indicates Improvement After Gene Replacement Therapy
por: Vannoy, Charles Harvey, et al.
Publicado: (2019)

A new patient‐derived iPSC model for dystroglycanopathies validates a compound that increases glycosylation of α‐dystroglycan
por: Kim, Jihee, et al.
Publicado: (2019)

The conserved WW-domain binding sites in Dystroglycan C-terminus are essential but partially redundant for Dystroglycan function
por: Yatsenko, AS, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_4bp93grpjph5mbn9pgt1cbuut9